Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Amare Aregay"'
Autor:
Amare Aregay, Jan Slunečko, Miša Korva, Petra Bogovic, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Tatjana Avšič-Županc, Imke Steffen, Franc Strle, Albert D. M. E. Osterhaus, Guus F. Rimmelzwaan
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-9 (2024)
Abstract Tick-borne encephalitis virus (TBEV) vaccine breakthrough (VBT) infections are not uncommon in endemic areas. The clinical and immunological outcomes have been poorly investigated. We assessed the magnitude and specificity of virus-specific
Externí odkaz:
https://doaj.org/article/cf5b01988b3348ca856aae149d908d63
Autor:
Amare Aregay, Jan Slunečko, Petra Bogovic, Miša Korva, Katarina Resman Rus, Nataša Knap, Jana Beicht, Mareike Kubinski, Giulietta Saletti, Imke Steffen, Franc Strle, Tatjana Avšič-Županc, Albert D.M.E. Osterhaus, Guus F. Rimmelzwaan
Publikováno v:
Emerging Microbes and Infections, Vol 13, Iss 1 (2024)
ABSTRACTTick-borne encephalitis virus (TBEV) infection may cause acute central nervous system inflammation varying in clinical manifestations and severity. A possible correlation of TBEV-specific antibody and cell-mediated immune responses, shortly a
Externí odkaz:
https://doaj.org/article/8322d2c58d7a4e8190e93eb9a95a774a
Autor:
Mareike Kubinski, Jana Beicht, Thomas Gerlach, Amare Aregay, Albert D. M. E. Osterhaus, Alina Tscherne, Gerd Sutter, Chittappen Kandiyil Prajeeth, Guus F. Rimmelzwaan
Publikováno v:
Vaccines, Vol 12, Iss 1, p 105 (2024)
Tick-borne encephalitis (TBE) is a serious neurological disease caused by TBE virus (TBEV). Because antiviral treatment options are not available, vaccination is the key prophylactic measure against TBEV infections. Despite the availability of effect
Externí odkaz:
https://doaj.org/article/6995d27a9c67459589803e595b8ce85e
Autor:
Markus Cornberg, Yanqin Du, Tanvi Khera, Katja Deterding, Eike Steinmann, Svenja Hardtke, Julia Hengst, Heiner Wedemeyer, Daniel Todt, Niklas K. Björkström, Kerstin Port, Michael P. Manns, Matthias Hardtke-Wolenski, Benedikt Strunz, Amare Aregay
Background Treatment with direct-acting antivirals (DAAs) in patients with chronic hepatitis C infection leads to partial restoration of soluble inflammatory mediators (SIMs). In contrast, we hypothesized that early DAA treatment of acute hepatitis C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ec58c1fe02296cb6afad4d2833bd94
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85158828843
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85158828843
Autor:
Markus Cornberg, Richard Taubert, Kerstin Port, Christian E. Niehaus, Bastian Engel, Birgit Bremer, Nicolas Richter, Florian W. R. Vondran, Tanvi Khera, Heiner Wedemeyer, Elmar Jaeckel, Amare Aregay
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
United States
United States
Recurrence or de novo infection of hepatitis C virus (HCV) after liver transplantation (LT) has been associated with progressive graft hepatitis that can be improved by treatment with novel direct-acting antivirals. Cases of rejection episodes have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbf6d3851f04afc6b46bbed839d76e84
https://hdl.handle.net/10033/622949
https://hdl.handle.net/10033/622949
Autor:
Amare Aregay, Richard Taubert, Kerstin Port, Michael P. Manns, Elmar Jaeckel, Nicolas Richter, Markus Cornberg, Heiner Wedemeyer
Publikováno v:
Journal of Hepatology. 73:S283
Autor:
Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, Kim Haag, Birgit Bremer, Meike Dirks, Karin Weissenborn, Henning Pflugrad, Julia Hengst, Ramona Schuppner, Verena Schlaphoff, Christine S. Falk, Amare Aregay, Solomon Owusu Sekyere
Background & aims Chronic inflammatory liver diseases are frequently associated with neuropsychiatric and cognitive dysfunctions. We hypothesized that symptomatic patients may show altered levels of soluble inflammatory mediators (SIMs) as well as ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6776efc8072826446d4716b07a9803cc
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85057173254
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85057173254
Autor:
Bernhard Schlevogt, Katja Deterding, Thomas Wirth, M. Cornberg, Arndt Vogel, H. Wedemeyer, Solomon Owusu Sekyere, Christine S. Falk, M.P. Manns, Amare Aregay
Publikováno v:
Journal of Hepatology. 66:S2